SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Sep-19 4:19 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Sep-19 | Market Sale | 1,584 | $6.91 | $10,945.40 | (3%) 49.6K to 48.02K | (19%) |
10-Apr-19 4:24 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 08-Apr-19 | Grant | 25,000 | -- | -- | 102% 24.6K to 49.6K | |
21-Mar-19 4:47 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Mar-19 | Market Sale | 857 | $7.99 | $6,847.43 | (3%) 25.46K to 24.6K | (3%) |
21-Sep-18 7:12 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Sep-18 | Market Sale | 1,665 | $19.18 | $31,934.70 | (6%) 27.13K to 25.46K | 57% |
09-Mar-18 8:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 06-Mar-18 | Grant | 8,375 | -- | -- | 45% 18.75K to 27.13K | |
10-Jul-17 5:54 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 10-Jul-17 | Grant | 18,750 | -- | -- | 100% 0 to 18.75K | |
12-May-11 7:47 PM View: | Celera Corp (CRA) | 10-May-11 | Disposition (change in control) | 15,828 | $8.00 | $126,624.00 | (100%) 15.83K to 0 | (< 1%) |
06-May-11 8:12 PM View: | Celera Corp (CRA) | 03-May-11 | Payment of Exercise | 9,172 | $8.00 | $73,376.00 | (37%) 25.0K to 15.83K | (< 1%) |
04-Jan-11 5:11 PM View: | Celera Corp (CRA) | 03-Jan-11 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
10-Dec-04 6:06 PM View: | Aclara Biosciences Inc (ACLA) | 10-Dec-04 | Disposition | 5,908 | -- | -- | (100%) 5.91K to 0 |